Three year follow up of levodopa plus carbidopa treatment in a prevalent cohort of patients with Parkinson's disease in Hai, Tanzania

Journal of Neurology

Volumn 258, Issue 9, 2011, Pages 1649-1656

  Dotchin, Catherine ^a   Jusabani, Ahmed ^b   Walker, Richard ^c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b KILIMANJARO CHRISTIAN MEDICAL CENTRE   (Tanzania)

^c NORTH TYNESIDE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Levodopa; Mortality; Parkinson's disease; Sub Saharan Africa

Indexed keywords

CARBIDOPA PLUS LEVODOPA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONFUSION; CONSTIPATION; CONTROLLED STUDY; DECUBITUS; DEMENTIA; DISEASE COURSE; DISEASE DURATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DYSKINESIA; FEASIBILITY STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; NAUSEA; ORTHOSTATIC HYPOTENSION; PARKINSON DISEASE; PRIORITY JOURNAL; TANZANIA; TREATMENT RESPONSE; URINE INCONTINENCE; VISUAL HALLUCINATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; CARBIDOPA; COHORT STUDIES; DRUG THERAPY, COMBINATION; DYSKINESIA, DRUG-INDUCED; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; PREVALENCE; RETROSPECTIVE STUDIES; TANZANIA;

EID: 80054729695     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-011-5988-y     Document Type: Article

References (33)

1. C Dotchin, et al. 2008 The prevalence of Parkinson's disease in rural Tanzania Mov Disord 23 11 1567 1572 18581482 10.1002/mds.21898
2. CL Dotchin A Jusabani RW Walker 2009 Non-motor symptoms in a prevalent population with Parkinson's disease in Tanzania Parkinsonism Relat Disord 15 6 457 460 19196538 10.1016/j.parkreldis.2008.11.013 1:STN:280: DC%2BD1MvktlChuw%3D%3D
3. N Okubadejo, et al. 2006 Parkinson's disease in Africa: a systematic review of epidemiologic and genetic studies Mov Disord 21 12 2150 2156 17044056 10.1002/mds.21153 (Pubitemid 46140428)
4. BO Osuntokun, et al. 1987 Neurological disorders in Nigerian Africans: a community-based study Acta Neurol Scand 75 1 13 21 3033973 10.1111/j.1600-0404. 1987.tb07883.x 1:STN:280:DyaL2s3gvV2hsQ%3D%3D (Pubitemid 17027275)
5. R Tekle-Haimanot, et al. 1990 Community-based study of neurological disorders in rural central Ethiopia Neuroepidemiology 9 5 263 277 2087251 10.1159/000110783 1:STN:280:DyaK3M3gsVWjug%3D%3D
6. AAK Balogou A Doh KE Grunitzky 2001 Affectations neurologiques et endemie goitreuse: analyse comparative de deux provinces du Togo Bull Soc Pathol Exot 94 5 406 410 11889943 1:STN:280:DC%2BD387lvVemsA%3D%3D (Pubitemid 33739552)
7. MM Wickrematchi, et al. 2009 Prevalence and age at onset of Parkinson's disease in Cardiff: a community based cross sectional study and meta-analysis J Neurol Neurosurg Psychiatry 80 805 807 10.1136/jnnp.2008.162222
8. ZX Zhang, et al. 2005 Parkinson's disease in China: prevalenc in Beijing, Xian and Shanghai Lancet 365 9459 595 597 15708103
9. SK Das, et al. 2010 Epidemiology of Parkinson disease in the city of Kolkata, India: a community-based study Neurology 75 15 1362 1369 20938028 10.1212/WNL.0b013e3181f735a7 1:STN:280:DC%2BC3cfoslCgtw%3D%3D
10. CL Dotchin O Msuya RW Walker 2007 The challenge of Parkinson's disease management in Africa Age Ageing 36 2 122 127 17261529 10.1093/ageing/afl172 1:STN:280:DC%2BD2s7kvVehug%3D%3D (Pubitemid 46455389)
11. J Harries 1972 L-dopa in the treatment of parkinsonism in Africans East Afr Med J 49 2 112 115 5047267 1:STN:280:DyaE383kt1alug%3D%3D
12. J Carr, et al. 2009 Guideline for the treatment of Parkinson's disease Samj S Afr Med J 99 10 755 758 1:STN:280:DC%2BC3c%2FosVWitw%3D%3D
13. Fahn S, Elton RL (1987) Unified Parkinson's Disease Rating Scale. In: Fahn S et al (eds) Recent Developments in Parkinson's Disease. Macmillan Healthcare Information, Florham Park
14. K Chaudhuri, et al. 2006 The international PD non-motor group: an international questionnaire for Parkinson's disease: the NMS Quest Mov Disord 21 7 916 923 16547944 10.1002/mds.20844 (Pubitemid 44184590)
15. D Podsiadlo S Richardson 1991 The timed "up and and go" J Am Geriatr Soc 39 142 148 1991946 1:STN:280:DyaK3M7itlKgsA%3D%3D
16. M Hoehn M Yahr 1967 Parkinsonism: onset, progression and mortality Neurology 17 427 442 6067254 1:STN:280:DyaF2s7jvFSgsg%3D%3D
17. NU Okubadeio FI Ojini MA Danesi 2005 Longitudinal study of mortality predictors in Parkinson's disease in Nigerians Afr J Med Med Sci 34 4 365 369
18. R Haimanot 1985 Parkinson's disease in Ethiopia: a prospective study of 70 patients East Afr Med J 62 8 571 579 4054032 1:STN:280:DyaL28%2FjtVSksQ%3D%3D (Pubitemid 15021889)
19. BO Osuntokun O Bademosi 1979 Parkinsonism in the Nigerian Africa: a prospective study of 217 patients East Afr Med J 56 11 597 607 520239 1:STN:280:DyaL3c%2FptFChsQ%3D%3D (Pubitemid 10182845)
20. A Ogunniyi 1997 Treatment of parkinsonian syndromes in developing countries Afr J Med Med Sci 26 1-2 101 103 10895245 1:STN:280: DC%2BD3czptVSksg%3D%3D
21. GF Wooten, et al. 2004 Are men at greater risk of Parkinson's disease than women? J Neurol Neurosurg Psychiatry 75 637 639 15026515 10.1136/jnnp.2003.020982 1:STN:280:DC%2BD2c7jsVShsQ%3D%3D (Pubitemid 38406668)
22. R Mayeux, et al. 1995 The frequency of idiopathic Parkinson's disease by age, ethnic group and sex in Northern Manhatten, 1988-1993 Am J Epidemiol 142 8 820 827 7572958 1:STN:280:DyaK28%2FhslCjtw%3D%3D
23. JE Ahlskog MD Muenter 2001 Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature Mov Disord 16 3 448 458 11391738 10.1002/mds.1090 1:STN:280:DC%2BD3MzitVCmtg%3D%3D (Pubitemid 36041148)
24. WH Poewe GK Wenning 1996 The natural history of Parkinson's disease Neurology 47 6 Suppl 3 S146 S152 8959983 1:STN:280:DyaK2s7hvFWlsg%3D%3D
25. DATATOP: a multicenter controlled clinical trial in early Parkinson's disease (1989) Archives Neurology 46(10):1052-60
26. Fahn S (1992) Adverse effects of levodopa. In: Olanow CW, Lieberman AN (eds) The scientific basis for the treatment of Parkinson's disease. Parthenon Publishing Group, London
27. Parkinson Study Group (1996) Impact of deprenyl and tocopherol treatment on Parkinson's disease in DATATOP patients requiring levodopa. Ann Neurol 39(1): 37-45
28. WC Koller, et al. 1999 Immediate-release and controlled-release carbidopa/levodopa in PD: a 5-year randomized multicenter study. Carbidopa/levodopa study group Neurology 53 5 1012 1019 10496260 1:CAS:528:DyaK1MXmsFersL4%3D (Pubitemid 29442117)
29. A Schrag N Quinn 2000 Dyskinesias and motor fluctuations in Parkinson's disease. A community-based study Brain 123 Pt 11 2297 2305 11050029 10.1093/brain/123.11.2297
30. M Onofrj C Paci T Thomas 1998 Sudden appearance of invalidating dyskinesia-dystonia and off fluctuations after the introduction of levodopa in two dopaminomimetic drug naive patients with stage IV Parkinson's disease J Neurol Neurosurg Psychiatry 65 4 605 606 9771801 10.1136/jnnp.65.4.605 1:STN:280:DyaK1cvkt1Ontg%3D%3D (Pubitemid 28438907)
31. N Okubadejo M Danesi 2004 Frequency and predictors of autonomic dysfunction in Parkinson's disease: a study of African patients in Lagos, Nigeria Niger Postgrad Med J 11 1 45 49 15254572 1:STN:280: DC%2BD2czls1OgsA%3D%3D
32. WBP Matuja EA Aris 2008 Motor and non-motor features of Parkinson's disease East Afr Med J 85 1 3 9 18543520 1:STN:280:DC%2BD1cznsF2quw%3D%3D
33. Rochester L et al (2010) The effect of cueing therapy on single and dual-task gait in a drug naive population of people with Parkinson's disease in northern Tanzania. Mov Disord 25(7):906-911